Hims & Hers Health (HIMS) stock hit a new all-time high on Thursday as retail investors have taken interest in the telehealth ...

One developer of a weight loss medication, clinical-stage biotech Structure Therapeutics ( GPCR 0.16%), was a victim of a ...

Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...

Telehealth stock Hims & Hers (HIMS) spiked more than 24% in trading Thursday, days after its Super Bowl ad promoting cheaper GLP-1 weight-loss drugs sparked controversy. The ad criticized the American ...

Food and drug companies have expressed optimism, but the new health secretary and his MAHA movement will likely make waves.

EXCLUSIVE: Premiere Entertainment Group has licensed North American rights to Vertical for the family comedy F+, starring six ...

Trump’s tariffs on products from the EU and TK add to a big trade bill that will hit U.S. states, with Texas and California ...

Restaurant Brands International, McDonald’s and Canadian Tire Corp. also reported earnings this week. Here are the details ...

In the assessment done by DelveInsight, the estimated total diagnosed prevalent cases of chronic kidney disease in the US ...

Nvidia disclosed in a regulatory filing Friday that it sold off three tech stocks and added stakes in two others. Nvidia ...